Company
Infinity Bio
We Decipher the Antibody Reactome
Also known as Infinity Bio Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- research, biopharma, and translational communities
- Legal name
- Infinity Bio Inc.
- infinitybio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Infinity Bio, Inc. is a technology company that provides detailed insights into the immune system using its proprietary antibody reactome profiling platform.
Funding snapshot
- Total raised
- $11.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series A, $8M2025-06-18
Funding rounds
- Series A
- $8M2025-06-18, Company stated
- Round, 2025
- $5M2025-06-13, SEC form D sold, 1 investor
- Round, 2025
- $2M2025-02-18, SEC form D sold, 2 investors
- Round, 2023
- $4.5M2023-06-16, SEC form D sold, 1 investor
Products
- Other
- EnviroSIGHT™
- Other
- HuSIGHT™
- Other
- MuSIGHT™
- Other
- VirSIGHT™
Loading relationship preview